IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
-
- Xiaoxiao Liu
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan
-
- Naru Sato
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Tomohiro Yabushita
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Jingmei Li
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan
-
- Yuhan Jia
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan
-
- Moe Tamura
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan
-
- Shuhei Asada
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Takeshi Fujino
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Tsuyoshi Fukushima
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Taishi Yonezawa
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan
-
- Yosuke Tanaka
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Tomofusa Fukuyama
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Akiho Tsuchiya
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Shiori Shikata
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Hiroyuki Iwamura
- FUJIFILM Corporation: Pharmaceutical Products Division Tokyo Japan
-
- Chieko Kinouchi
- FUJIFILM Corporation: Bio Science & Engineering Laboratories Kanagawa Japan
-
- Kensuke Komatsu
- FUJIFILM Corporation: Bio Science & Engineering Laboratories Kanagawa Japan
-
- Satoshi Yamasaki
- Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Tatsuhiro Shibata
- Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Atsuo T Sasaki
- Division of Hematology and Oncology, Department of Internal Medicine University of Cincinnati Cincinnati OH USA
-
- Janet Schibler
- Division of Experimental Hematology and Cancer Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA
-
- Mark Wunderlich
- Division of Experimental Hematology and Cancer Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA
-
- Eric O'Brien
- Division of Oncology, Department of Pediatrics, University of Cincinnati Cincinnati OH USA
-
- Benjamin Mizukawa
- Division of Experimental Hematology and Cancer Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA
-
- James C Mulloy
- Division of Experimental Hematology and Cancer Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA
-
- Yuki Sugiura
- Department of Biochemistry Keio University School of Medicine Tokyo Japan
-
- Hitoshi Takizawa
- Laboratory of Stem Cell Stress, International Research Center for Medical Sciences Kumamoto University Kumamoto Japan
-
- Takuma Shibata
- Division of Innate Immunity, Department of Microbiology and Immunology The Institute of Medical Science, The University of Tokyo Tokyo Japan
-
- Kensuke Miyake
- Division of Innate Immunity, Department of Microbiology and Immunology The Institute of Medical Science, The University of Tokyo Tokyo Japan
-
- Toshio Kitamura
- Division of Cellular Therapy, The Institute of Medical Science The University of Tokyo Tokyo Japan
-
- Susumu Goyama
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan
収録刊行物
-
- EMBO Molecular Medicine
-
EMBO Molecular Medicine 15 (1), 2022-12
Springer Science and Business Media LLC
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360017279838602624
-
- ISSN
- 17574684
- 17574676
-
- データソース種別
-
- Crossref
- KAKEN